Jefferies lowered the firm’s price target on Varonis (VRNS) to $60 from $75 and keeps a Buy rating on the shares. The end of life for the 24% of ARR that is on-premise by the end of 2026 was “surprising,” but there is precedent of “ripping the Band-Aid off SaaS conversions” unlocking shareholder value, as long as there’s no competitive issues and management is adamant there’s not, the analyst tells investors in a post-earnings note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis Systems: Strategic Adjustments Amidst Challenges Support Buy Rating
- Varonis price target lowered to $50 from $70 at Barclays
- Varonis Systems: Buy Rating Affirmed Amid SaaS Growth and Strategic Adjustments
- Varonis Systems Reports Strong SaaS Growth Amid Strategic Shifts
- Closing Bell Movers: Bloom Energy, Teradyne both up 20% on earnings